Crohn's disease therapy (FCB-Pharmicell)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCrohn's disease therapy (FCB-Pharmicell)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCrohn Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesFcb-Pharmicell

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesFcb-Pharmicell

Active IndicationsN/A

Inactive IndicationsCrohn Disease

ATC CodeN/A